Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
Status:
Recruiting
Trial end date:
2024-02-29
Target enrollment:
Participant gender:
Summary
This study is being done to test the safety and efficacy of the study drug LY3556050 for the
treatment of diabetic peripheral neuropathic pain. This trial is part of the chronic pain
master protocol (H0P-MC-CPMP) which is a protocol to accelerate the development of new
treatments for chronic pain.